As the cost of health care continues to rise, so do the expectations for access to quality, affordable health care.  Payers, providers, and patients rely on clinical and economic evidence to make informed and cost-effective treatment decisions. 

The demand for this evidence is increasing, and pharmaceutical, biopharmaceutical, and medical device companies have an opportunity to demonstrate the value of their products with the strategic generation of health economic and outcomes research (HEOR) evidence throughout product development, and in real world practice settings.

At its core, the ability to demonstrate product value lies in the evidence that is developed and the degree to which it is effectively communicated to stakeholders and decision makers. 

CorEvidence Research & Consulting provides HEOR services that help characterize product value through both prospective and retrospective research approaches. 

Underlying these services is the development of a sound strategy, which provides the foundation and the “road map” for generating, synthesizing, and communicating the evidence needed to define product value. We help clients create and implement relevant HEOR strategies and tactics from the early stages of clinical development through post-launch.  Click here to learn more about us.

Click to Replace
Follow Us On: